Login to Your Account

Cempra's storm-tossed journey ends with Melinta merger deal

By Randy Osborne
Staff Writer

Wednesday, August 9, 2017

Privately held Melinta Therapeutics Inc. had "been interested in this transaction for quite some time," Lyn Baranowski, vice president of corporate development and strategy, told BioWorld.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription